Karsten Mäder

9.5k total citations · 1 hit paper
200 papers, 7.5k citations indexed

About

Karsten Mäder is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Karsten Mäder has authored 200 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pharmaceutical Science, 53 papers in Molecular Biology and 53 papers in Biomaterials. Recurrent topics in Karsten Mäder's work include Advanced Drug Delivery Systems (31 papers), Drug Solubulity and Delivery Systems (29 papers) and Nanoparticle-Based Drug Delivery (27 papers). Karsten Mäder is often cited by papers focused on Advanced Drug Delivery Systems (31 papers), Drug Solubulity and Delivery Systems (29 papers) and Nanoparticle-Based Drug Delivery (27 papers). Karsten Mäder collaborates with scholars based in Germany, Switzerland and United States. Karsten Mäder's co-authors include W. Mehnert, Sabine Kempe, H. Metz, Gerd Hause, Jörg Kreßler, Andreas Briel, Thomas Mueller, Ahmed Besheer, Harold M. Swartz and Thomas Kissel and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Karsten Mäder

195 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Solid lipid nanoparticles

2012 680 citations Karsten Mäder et al. profile →

Peers

Countries citing papers authored by Karsten Mäder

Since Specialization

Citations

This map shows the geographic impact of Karsten Mäder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Mäder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Mäder more than expected).

Fields of papers citing papers by Karsten Mäder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karsten Mäder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Mäder. The network helps show where Karsten Mäder may publish in the future.

Co-authorship network of co-authors of Karsten Mäder

This figure shows the co-authorship network connecting the top 25 collaborators of Karsten Mäder. A scholar is included among the top collaborators of Karsten Mäder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karsten Mäder. Karsten Mäder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interfacial and self-association behaviour of poloxamer 188 in aqueous solutions 2025 ·Journal of Molecular Liquids ·(unknown), (unknown), Stefan Gröger, Patrick Garidel, Karsten Mäder	5
2	PROTAC Enabling Formulation In Vivo: Implications of the Polymeric Carrier Eudragit E PO 2025 ·Molecular Pharmaceutics ·Nicole Hofmann, Florian Johann, (unknown), (unknown), (unknown), Marc Lecomte, Meike Harms, Karsten Mäder	0
3	Photo-thermoresponsive polypyrrole-crosslinked single-chain nanoparticles for photothermal therapy 2025 ·Communications Chemistry ·(unknown), (unknown), (unknown), Jan Laufer, Henrike Lucas, (unknown), Karsten Mäder, Wolfgang H. Binder	1
4	Impact of stabilizers on particle size and dispersion behavior in biorelevant media in solid nanocrystal formulations 2025 ·European Journal of Pharmaceutics and Biopharmaceutics ·Nathalie Bock, (unknown), Mirko Koziolek, (unknown), Karsten Mäder	3
5	Preclinical Validation of MIN-T: A Novel Controlled-Released Formulation for the Adjunctive Local Application of Minocycline in Periodontitis 2024 ·Antibiotics ·(unknown), Piotr Mydel, Karsten Mäder, (unknown), Nadine Taudte, (unknown), (unknown), (unknown), Andreas Kiesow, Sigrun Eick, Mirko Buchholz	1
6	Synthesis and Characterization of Dimeric Artesunate Glycerol Monocaprylate Conjugate and Formulation of Nanoemulsion Preconcentrate 2023 ·Molecules ·(unknown), (unknown), Karsten Mäder, Jörg Kreßler	2
7	Applicability of Redirecting Artemisinins for New Targets 2023 ·SHILAP Revista de lepidopterología ·Jacob Golenser, Nicholas H. Hunt, (unknown), Charles L. Jaffe, (unknown), Karsten Mäder, Daniel Gold	4
8	Comparative Stability Study of Polysorbate 20 and Polysorbate 80 Related to Oxidative Degradation 2023 ·Pharmaceutics ·(unknown), Johanna Weber, Julia Buske, Karsten Mäder, Patrick Garidel, (unknown)	24
9	Poloxamer 188 as surfactant in biological formulations – An alternative for polysorbate 20/80? 2022 ·International Journal of Pharmaceutics ·(unknown), Julia Buske, Karsten Mäder, Patrick Garidel	93
10	Conjugation of Amine-Functionalized Polyesters With Dimethylcasein Using Microbial Transglutaminase 2019 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), Karsten Mäder, Markus Pietzsch, Jörg Kreßler	11
11	Extrudates of lipophilic tetracycline complexes: A new option for periodontitis therapy 2019 ·International Journal of Pharmaceutics ·(unknown), Sigrun Eick, Mirko Buchholz, Andreas Kiesow, (unknown), Karsten Mäder	10
12	Improved Tumor-Specific Drug Accumulation by Polymer Therapeutics with pH-Sensitive Drug Release Overcomes Chemotherapy Resistance 2016 ·Molecular Cancer Therapeutics ·(unknown), Henrike Lucas, (unknown), Petr Chytil, Tomáš Etrych, Karsten Mäder, Thomas Mueller	30
13	Synthesis, Characterization, and Nanoencapsulation of Tetrathiatriarylmethyl and Tetrachlorotriarylmethyl (Trityl) Radical Derivatives—A Study To Advance Their Applicability as in Vivo EPR Oxygen Sensors 2015 ·The Journal of Organic Chemistry ·(unknown), (unknown), Mohamed M. Said, (unknown), Mohamed El‐Sadek, Diana Müller, Annette Meister, Gerd Hause, Simon Drescher, H. Metz, Peter Imming, Karsten Mäder	24
14	Monitoring of Xenograft Tumor Growth and Response to Chemotherapy by Non-Invasive In Vivo Multispectral Fluorescence Imaging 2012 ·PLoS ONE ·Henrike Caysa, Stefan Hoffmann, Jana Luetzkendorf, Lutz Peter Mueller, Susanne Unverzagt, Karsten Mäder, Thomas Mueller	21
15	Characterization of Scaffolds for Tissue Engineering by Benchtop-Magnetic Resonance Imaging 2009 ·Tissue Engineering Part C Methods ·(unknown), H. Metz, (unknown), Anke Bernstein, Gerd Hause, Thomas Groth, Karsten Mäder	22
16	Benchtop-NMR and MRI—A new analytical tool in drug delivery research 2008 ·International Journal of Pharmaceutics ·H. Metz, Karsten Mäder	68
17	Modulating pH-independent release from coated pellets: Effect of coating composition on solubilization processes and drug release 2008 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), H. Metz, (unknown), Karsten Mäder	24
18	Sucrose ester nanodispersions: Microviscosity and viscoelastic properties 2008 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), H. Metz, Karsten Mäder	22
19	Preparation and characterization of a self-emulsifying pellet formulation 2006 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Karsten Mäder	104
20	In Vitro/In Vivo Comparison of Drug Release and Polymer Erosion from Biodegradable P(FAD-SA) Polyanhydrides—A Noninvasive Approach by the Combined Use of Electron Paramagnetic Resonance Spectroscopy and Nuclear Magnetic Resonance Imaging 1997 ·Pharmaceutical Research ·Karsten Mäder, (unknown), Abraham J. Domb, (unknown), Harold M. Swartz	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact